Device and drug manufacturers got a small surprise in the annual Physician Fee Schedule proposed rule (at 40,713-16) issued late in July by the Centers for Medicare & Medicaid Services (CMS) – among many other things, the proposed rule would make a few changes to manufacturer reporting requirements under the Open Payments program.
Please see full publication below for more information.
